Pfizer and its partner BioNTech asked US regulators Tuesday to authorize an additional booster dose of their Covid-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.
AMWAJ Real Estate
Pfizer and its partner BioNTech asked US regulators Tuesday to authorize an additional booster dose of their Covid-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.